Activation of CD47 in T cells mainly leads to the suppression of their immune response, while the interaction of CD47 with SIRPα or TSP-1 induces proliferation and activation of antigen-specific T cells, thereby improving the immune response to cancer cells [51]. Here, CD47 is linked to cancer.